Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro

Platelets

Volumn 19, Issue 2, 2008, Pages 155-159

  Foss, Brynjar ^a   Bruserud, Øystein ^b   Hervig, Tor ^c  

^a UNIVERSITY OF STAVANGER   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Apheresis; Hematopoietic stem cells; Peripheral blood stem cell transplantation; Platelet activation; Platelet released supernatants

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; THROMBIN; THROMBOCYTE FACTOR 4; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

APHERESIS; ARTICLE; AUTOGRAFT; CD34 SELECTION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKOCYTE; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SUPERNATANT; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; BLOOD PLATELETS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLACENTA; PLATELET ACTIVATION; PREGNANCY;

EID: 39749092310     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701767288     Document Type: Article

References (21)

1. Stroncek DF, Clay ME, Jaszcz W, Lennon S, Smith J, McCullough J. Collection of two peripheral blood stem cell concentrates from healthy donors. Transfus Med 1999;9:37-50.
2. Stroncek DF, Clay ME, Smith J, et al. Composition of peripheral blood progenitor cell components collected from healthy donors. Transfusion 1997;37:411-417.
3. Foss B, Abrahamsen JF, Bruserud Ø. Peripheral blood stem cell grafts contain high levels of platelet-secreted mediators. Transfusion 2001;41:1431-1437.
4. Saigo K, Kumagai S, Sugimoto T, Matsui T, Ryo R. RANTES and p-Selectin in peripheral blood stem. Ther Apher Dial 2001;5:517-518.
5. Voss R, Scarlat T, Matzdorff A, Tillmanns H. Flow cytometric detection of platelet activation in patients undergoing diagnostic and interventional coronary angiography. Platelets 1996;7:237-241.
6. Gutensohn K, Bartsch N, Kuehnl P. Flow cytometric analysis of platelet membrane antigens during and after continuous-flow plateletpheresis. Transfusion 1997;37:809-815.
7. Gutensohn K, Maerz M, Kuehnl P. Alteration of platelet-associated membrane glycoproteins during extracorporeal apheresis of peripheral blood progenitor cells. J Hematother 1997;6:315-321.
8. Bruserud Ø, Foss B, Abrahamsen JF, Gjertsen BT, Ernst P. Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: Does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse? J Hematother Stem Cell Res 2000;9:433-443.
9. Turner CW, Luzins J, Hutcheson C. A modified harvest technique for cord blood hematopoietic stem cells. Bone Marrow Transplant 1992;10:89-91.
10. Bruserud Ø, Foss B, Hervig T. Effects of normal platelets on proliferation and constitutive cytokine secretion by human acute myelogenous leukaemia blasts. Platelets 1997;8:397-404.
11. Nomura S, Inami N, Kanazawa S, Iwasaka T, Fukuhara S. Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF. Stem Cells 2004;22:696-703.
12. Foss B, Ulvestad E, Bruserud Ø. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia (AML): PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured AML blasts. Eur J Haematology 2001;66:365-376.
13. Foss B, Mentzoni L, Bruserud Ø. Effects of vascular endothelial growth factor (VEGF) on acute myelogenous leukemia blasts. J Hematother Stem Cell Res 2001;10:81-94.
14. Bruserud Ø, Foss B, Petersen H. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: Studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L). Eur Cytokine Netw 2001;12:231-238.
15. DiCuccio MN, Shami P, Hoffman M. A functional tethered ligand thrombin receptor is present on human hematopoietic progenitor cells. Exp Hematol 1996;24:914-918.
16. Plantier JL, Berthier R, Rival Y, Schweitzer A, Rabiet M. Evidence for a selective inhibitory effect of thrombin on megakaryocyte progenitor growth mediated by the thrombin receptor. Br J Haematol 1994;87:755-762.
17. Anitua E, Andí I, Sanchez M, Azofra J, Zaldueno M del Mar, Fuenta M, Nurden P, Nurden AT. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005;23:281-286.
18. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, Bugge TH. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000;96:3302-3309.
19. Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J, Reca R, Janowska-Wieczorek A, Ratajczak MZ. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002;30:450-459.
20. Komatsu N, Suda T, Sakata Y, Eguchi M, Kaji K, Saito M, Miura Y. Megakaryocytopoiesis in vitro of patients with essential thrombocythaemia: Effect of plasma and serum on megakaryocytic colony formation. Br J Haematol 1986;64:241-252.
21. Mitjavila MT, Vinci G, Villeval JL, Kieffer N, Henri A, Testa U, Breton-Gorius J, Vainchenker W. Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: Its relationship to type beta transforming growth factor (TGF-beta). J Cell Physiol 1988;134:93-100.